NCT03652662

Brief Summary

30 adults, aged 40 and older with mild to moderate COPD, will be recruited for this study. Participants must be willing to continually wear a FitBit activity monitor, have access to a smartphone or Wi-Fi/Data-enabled iPad, and be willing to complete respiratory muscle strength training exercises as well as reports on their smartphone at least 5 times per week for a 6-week period. Participants will be given a bluetooth inhaler device and a training app (RESP-FIT). This application will collect inhaler data and allows patients to self-report their daily symptoms. The goal of this study is to test whether use of the personalized inhaler device with the app strengthens lung function, promotes physical activity, and improves disease symptom self-management in persons with COPD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 26, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 29, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 13, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 13, 2020

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

March 30, 2021

Completed
Last Updated

March 30, 2021

Status Verified

March 1, 2021

Enrollment Period

2 years

First QC Date

June 26, 2018

Results QC Date

January 12, 2021

Last Update Submit

March 4, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intervention Feasibility (Number of Participants Who Adhered to Treatment)

    Feasibility of intervention was measured by the number of participants who adhered to treatment and completed the trial (from baseline to final visit follow-up). Treatment acceptability was measured by the Mobile Application Rating Scale. The Mobile Application Rating Scale asks the participant to report the appropriateness of the app for his/her target audience ranging from little or no (1) to very high level of the acceptability measure (5).

    through study completion, average of 6 weeks

Secondary Outcomes (3)

  • Change in Self-efficacy

    baseline, 6 weeks

  • Change in Fatigue

    baseline, 6 weeks

  • Dyspnea

    baseline, 6 weeks

Study Arms (2)

RESP-FIT Intervention

EXPERIMENTAL

Intervention: IMST/EMST Training (5 breaths, 5 times a day, 5 times a week) Fitbit activity monitoring Daily symptom and training log entered into mobile application (SAMS)

Device: RESP-FIT

RESP-FIT Comparator

ACTIVE COMPARATOR

Active Comparator: Fitbit activity monitoring (Daily) Daily symptom and training log entered into mobile application (SAMS)

Behavioral: RESP-FIT Comparator

Interventions

RESP-FITDEVICE

Inspiratory and Expiratory muscle strength training 5 times a week, plus Fitbit activity monitoring (Daily) Daily symptom and training log entered into mobile application (SAMS)

Also known as: Combined IMST/EMST
RESP-FIT Intervention

Fitbit activity monitoring (Daily) Daily symptom and training log entered into mobile application (SAMS)

Also known as: Activity and Symptom Monitoring Only
RESP-FIT Comparator

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older; and
  • Able to read and write English; and
  • Diagnosed with mild to moderate COPD (PFT values: FEV1/FVC \<0.7 and FEV1% predicted \< 50% - within the past 6 months); and
  • Dyspnea score of greater than "2" on the Modified Medical Research Council (MMRC) questionnaire.

You may not qualify if:

  • Pregnant female or less than 1 year post-partum; or
  • Diagnosed cognitive deficit or observed lack of understanding during the informed consent process; or
  • Mobility impairment; or
  • Lack of 3g WiFi access in place of residence; or
  • Unwillingness to wear physical activity tracker daily, follow protocol, and/ or attend study visits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Exercise

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Results Point of Contact

Title
Sarah Miller, PhD, RN
Organization
MUSC

Study Officials

  • Sarah Miller, PhD, RN

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This is a randomized longitudinal controlled observational study. The study will recruit 30 participants and utilize a control group experimental design with dependent pretest and posttest to derive data regarding (1) feasibility and (2) within-participant effect size of the RESP-FIT intervention in terms of satisfaction, use and adherence, technical issues and acceptability, and self-reported symptom severity (dyspnea and fatigue). When completed, 30 adults (15 in each group) will have used SAMS for 6 weeks.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2018

First Posted

August 29, 2018

Study Start

January 18, 2018

Primary Completion

January 13, 2020

Study Completion

January 13, 2020

Last Updated

March 30, 2021

Results First Posted

March 30, 2021

Record last verified: 2021-03

Locations